文献速递临床试验与 GCP真实世界研究与卫生经济

PREDOMOS 研究:针对社会隔离的老年癌症患者的社会干预项目影响的随机对照试验研究方案

PREDOMOS study, impact of a social intervention program for socially isolated elderly cancer patients: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2017-04-12

PREDOMOS 研究是一项在法国 10 个肿瘤老年中心开展的多中心、前瞻性、随机、安慰剂对照、开放标签、双臂平行试验,纳入年龄至少 70 岁、存在社会隔离风险且经组织学诊断为局部晚期或转移性癌症的患者,1:1 随机分为常规护理组与常规护理联合每月社会援助、家居自动化与远程援助组,主要终点为 3 个月时通过 EORTC QLQ C30 评估的生活质量。

要点

  • 主要终点为 3 个月时 EORTC QLQ C30 生活质量评分。
  • 计划样本量 320 例,按 1:1 随机分组,预计 20% 失访。
  • 试验在法国 10 个肿瘤老年中心开展,随访 12 个月。

核心结论

  • 该研究旨在评估社会干预联合家居自动化与远程援助项目对局部晚期或转移性癌症的老年社会隔离患者生活质量的改善作用。
  • 作者认为随机对照设计是证明新实验策略有效性的最合适设计,并指出国家和国际建议可根据本研究结果进行更新。

研究设计与样本

  • 多中心、前瞻性、随机、安慰剂对照、开放标签、双臂平行试验,在法国 10 个肿瘤老年中心开展。
  • 纳入标准为年龄至少 70 岁、存在社会隔离风险且经组织学诊断为癌症、局部晚期或转移性疾病。
  • 分组为对照组接受常规护理,实验组接受常规护理并联合每月社会援助、家居自动化与远程援助,按 1:1 比例随机分配。
  • 评估时间包括入组(随机化)和随访(12 个月)。
  • 样本量方面,需要 320 例受试者以获得 90% 把握度检测两组间生活质量评分 10 分差异(标准差 25),预计 20% 失访。

关键数值与推荐

  • 主要终点为 3 个月时生活质量(通过欧洲癌症研究与治疗组织 EORTC QLQ C30 评估)。
  • 次要终点包括社会隔离、治疗失败时间、毒性、剂量-反应强度、生存、自主性及 6 个月时生活质量。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cancer incidence and social isolation increase along with advanced age, and social isolation potentiates the relative risk of death by cancer. Once spotted, social isolation can be averted with the intervention of a multidisciplinary team. Techniques of automation and remote assistance have already demonstrated their positive impact on falls prevention and quality of life (QoL), though little is known about their impact on socially isolated elderly patients supported for cancer. The primary objective of the PREDOMOS study is to evaluate the impact of establishing a Program of Social intervention associated with techniques of Domotic and Remote assistance (PS-DR) on the improvement of QoL of elderly isolated patients, treated for locally advanced or metastatic cancer. The secondary objectives include treatment failure, tolerance, survival, and autonomy. METHODS/DESIGN: This trial is a multicenter, prospective, randomized, placebo-controlled, open-label, two-parallel group study. The setting is 10 French oncogeriatric centers. Inclusion criteria are patients aged at least 70 years with a social isolation risk and a histological diagnosis of cancer, locally advanced or metastatic disease. The groups are (1) the control group, receiving usual care; (2) the experimental group, receiving usual care associating with monthly social assistance, domotic, and remote assistance. Participants are randomized in a 1:1 allocation ratio. Evaluation times involve inclusion (randomization) and follow-up (12 months). The primary endpoint is QoL at 3 months (via European Organization for Research and Treatment of Cancer (EORTC) QLQ C30); secondary endpoints are social isolation, time to treatment failure, toxicity, dose response-intensity, survival, autonomy, and QoL at 6 months. For the sample size, 320 individuals are required to obtain 90% power to detect a 10-point difference (standard deviation 25) in QoL score between the two groups (20% loss to follow-up patients expected). DISCUSSION: The randomized controlled design is the most appropriate design to demonstrate the efficacy of a new experimental strategy (Evidence-Based Medicine Working Group classification). National and international recommendations could be updated based on the findings of this study. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02829762 . Registered on 29 June 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Crétel-Durand E, Nouguerède E, Le Caer H, et al. PREDOMOS study, impact of a social intervention program for socially isolated elderly cancer patients: study protocol for a randomized controlled trial. Trials. 2017. PMID: 28403911. doi:10.1186/s13063-017-1894-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。